EGI
REPL icon

EAM Global Investors’s Replimune Group REPL Stock Holding History

EAM Global Investors’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-57,817
Closed -$1.57M – 169
2022
Q4 		$1.57M Buy
+57,817
New +$1.2M 0.41% 131
2020
Q4 		– Sell
-54,274
Closed -$1.25M – 172
2020
Q3 		$1.25M Sell
54,274
-19,063
-26% -$434K 0.46% 106
2020
Q2 		$1.82M Buy
+73,337
New +$1.3M 0.82% 49

Other funds holding REPL

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

EAM Global Investors's REPL Position: Q1 2023 in Review

EAM Global Investors sold out of Replimune Group (REPL) in Q1 2023, closing a stake of 57,817 shares — an estimated $1.57M sold.

EAM Global Investors first reported a position in REPL in Q2 2020 and held it in 3 quarters. The position peaked at $1.82M in Q2 2020. 140 funds tracked by Wall St. Rank hold REPL as of Q1 2023.

  • EAM Global Investors reported no remaining Replimune Group position as of Q1 2023 after selling out during the quarter.
  • EAM Global Investors sold 57,817 Replimune Group shares in Q1 2023, an estimated $1.57M.
  • EAM Global Investors first reported a position in Replimune Group in Q2 2020 and held it in 3 quarters.
  • EAM Global Investors's Replimune Group position peaked at $1.82M in Q2 2020.
  • 140 funds tracked by Wall St. Rank held Replimune Group as of Q1 2023.

Based on EAM Global Investors's 13F filing for Q1 2023, filed 15 May 2023.